Who is the most at risk for atrial fibrillation? Dr. Rod Passman, Director, Center for Arrhythmia Research, Northwestern ...

Lu Chen, M.D., is a cardiologist specializing in electrophysiology with MyMichigan Physicians Group.

Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners ...

Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a quivering or irregular heartbeat that can lead to blood clots, stroke and heart ...

WICHITA, Kan. (KSNW) — Via Christi St. Francis has successfully performed a new, more precise treatment for atrial fibrillation. A-fib, as it is often referred to, is one of the most common forms of ...

On Monday, the American Heart Association and the American College of Cardiology updated the clinical performance and quality measures for the treatment of adults with atrial fibrillation or atrial ...

Add Yahoo as a preferred source to see more of our stories on Google. GRAND RAPIDS, Mich. (WOOD) — Doctors at Corewell Health say they have a new procedure that will give patients with atrial ...

A quivery heartbeat and a flutter in your chest are two telltale signs you could be in atrial fibrillation, or AFib. That means your heart is beating out of sync. As weird or scary as an episode may ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Previously, patients with advanced atrial fibrillation (AF ...

For patients who are scheduled for surgery, warfarin therapy should be discontinued 5 to 6 days before the procedure. 26 In patients who are at high risk for developing blood clots, the clinician may ...

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital is among the first in the country to successfully treat persistent atrial fibrillation and typical atrial flutter using a ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...